Fractionated cranial irradiation induces a distinctive pattern of second malignant neoplasms in Nf1 mutant mice

被引：0
|
作者：
Nakamura, J. L. [1 ]
Phong, C. [1 ]
Kogan, S. [1 ]
Vandenberg, S. [1 ]
Pieper, R. O. [1 ]
Shannon, K. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2008.06.953
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 33 条
  • [21] Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects
    Karlyne M. Reilly
    Dagan A. Loisel
    Roderick T. Bronson
    Margaret E. McLaughlin
    Tyler Jacks
    [J]. Nature Genetics, 2000, 26 : 109 - 113
  • [22] Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma
    Zhu, Y
    Guignard, F
    Zhao, DW
    Liu, L
    Burns, DK
    Mason, RP
    Messing, A
    Parada, LF
    [J]. CANCER CELL, 2005, 8 (02) : 119 - 130
  • [23] Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice (vol 123, pg 335, 2013)
    Chang, Tiffany
    Krisman, Kimberly
    Theobald, Emily Harding
    Xu, Jin
    Akutagawa, Jon
    Lauchle, Jennifer O.
    Kogan, Scott
    Braun, Benjamin S.
    Shannon, Kevin
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (01): : 404 - 404
  • [24] Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects
    Reilly, KM
    Tuskan, RG
    Christy, E
    Loisel, DA
    Ledger, J
    Bronson, RT
    Smith, CD
    Tsang, S
    Munroe, DJ
    Jacks, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (35) : 13008 - 13013
  • [25] CARBOPLATIN AND VINCRISTINE AS TREATMENT FOR PROGRESSIVE HYPOTHALAMIC/OPTIC PATHWAY GLIOMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND RISK OF SECOND MALIGNANT NEOPLASMS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP (COG)
    Ater, Joann
    Zhou, Tianni
    Holmes, Emiko
    Booth, Timothy
    Freyer, David
    Packer, Roger
    Vezina, Gilbert
    Wisoff, Jeffery
    Pollack, Ian F.
    [J]. PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1077 - 1078
  • [26] Vcp Overexpression and Leucine Supplementation Increase Protein Synthesis and Improve Fear Memory and Social Interaction of Nf1 Mutant Mice
    Shih, Yu-Tzu
    Huang, Tzyy-Nan
    Hu, Hsiao-Tang
    Yen, Tzu-Li
    Hsueh, Yi-Ping
    [J]. CELL REPORTS, 2020, 31 (13):
  • [27] MEK Inhibition Modulates the Growth of Nf1 mutant Hematopoietic Cells and Induces Clinical Improvement in a Murine Model of Juvenile Myelomonocytic Leukemia (JMML)
    Chang, Tiffany Y.
    Krisman, Kimberly
    Harding-Theobald, Emily Rose
    Braun, Benjamin S.
    Shannon, Kevin M.
    [J]. BLOOD, 2011, 118 (21) : 362 - 363
  • [28] Disease stage strongly modulates responsiveness to targeted agents in Nf1 mutant mice with myeloprolfierative disease (MPD) and acute myeloid leukemia (AML)
    Lauchle, JO
    Kim, DLD
    Tran, M
    Peterson, A
    Przybranowski, S
    Parada, L
    Wolff, L
    Leopold, J
    Shannon, KM
    [J]. BLOOD, 2005, 106 (11) : 148A - 149A
  • [29] Genome editing of Nf1, Pten, and Trp53 in neonatal mice induces glioblastomas positive for oligodendrocyte lineage transcription factor 2
    Yamamoto, Hiromi
    Yamamura, Keisuke
    Nagasaki, Haruka
    Suzuki, Takamasa
    Ninomiya, Fumiko
    Matsubara, Kenji
    Harada, Naomoto
    Ohkubo, Shuichi
    [J]. JOURNAL OF TOXICOLOGIC PATHOLOGY, 2021, 34 (04) : 359 - 365
  • [30] Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype
    Wiesner, Stephen M.
    Geurts, Jennifer L.
    Diers, Miechaleen D.
    Bergerson, Rachel J.
    Hasz, Diane E.
    Morgan, Kelly J.
    Largaespada, David A.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (07) : 579 - 585
1234